Table 1.

Inclusion and exclusion criteria used for monoclonal antibody-induced SCLE

Features	Inclusion
Morphology	Definite:
	Annular, polycylic  Erythema multiforme-like  Papulosquamous, plaques or papules with scale or desquamation, psoriasiform  ‘SCLE’ without exclusion terms
	Possible:
	Plaques or papules  Erythema with scale or desquamation
Serology	ANA-positive, anti-Ro antibody-positive OR ENA-positive
Photosensitivity	Lesions in sun-exposed areas: Face, neck OR arms
Histology	Prespecified: –IF dermatitis –Study synonyms: IF change, IF reaction, IF infiltrate, lichenoid reaction –‘Consistent with SCLE/lupus’  Supportive details included in cases: –Lymphocytic infiltrate of perivascular/dermoepidermal regions/junction/perifollicular/superficial/deep/dermis/epidermis –Parakeratosis, orthokeratosis, dyskeratosis, hyperkeratosis, necrotic/apoptotic keratinocytes –Mucin in dermis, colloid bodies, colloidal iron staining
	Exclusion
Morphology	Nonspecific/contradictory CLE terms in the absence of inclusion terms Chronic, discoid, tumidus, panniculitis, profundus, chilblain, atrophic, scarring Acute, malar, macular, butterfly Stevens–Johnson syndrome Palpable purpura, nodules, bullous

SCLE subacute cutaneous lupus erythematosus, ANA antinuclear antibody, ENA extractable nuclear antigen, IF interface, CLE cutaneous lupus erythematosus